Genetics and Genomics Approaches for Diagnosis and Research Into Hereditary Anemias.

chromatin 3D architecture differential diagnosis genetic test hereditary anemias next generation sequencing

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2020
Historique:
received: 02 10 2020
accepted: 03 12 2020
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 9 1 2021
Statut: epublish

Résumé

The hereditary anemias are a relatively heterogeneous set of disorders that can show wide clinical and genetic heterogeneity, which often hampers correct clinical diagnosis. The classical diagnostic workflow for these conditions generally used to start with analysis of the family and personal histories, followed by biochemical and morphological evaluations, and ending with genetic testing. However, the diagnostic framework has changed more recently, and genetic testing is now a suitable approach for differential diagnosis of these patients. There are several approaches to this genetic testing, the choice of which depends on phenotyping, genetic heterogeneity, and gene size. For patients who show complete phenotyping, single-gene testing remains recommended. However, genetic analysis now includes next-generation sequencing, which is generally based on custom-designed targeting panels and whole-exome sequencing. The use of next-generation sequencing also allows the identification of new causative genes, and of polygenic conditions and genetic factors that modify disease severity of hereditary anemias. In the research field, whole-genome sequencing is useful for the identification of non-coding causative mutations, which might account for the disruption of transcriptional factor occupancy sites and

Identifiants

pubmed: 33414725
doi: 10.3389/fphys.2020.613559
pmc: PMC7783452
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

613559

Informations de copyright

Copyright © 2020 Russo, Marra, Rosato, Iolascon and Andolfo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Genet. 2018 Dec;50(12):1744-1751
pubmed: 30374068
Orphanet J Rare Dis. 2019 May 23;14(1):114
pubmed: 31122244
J Clin Invest. 2012 Jul;122(7):2439-43
pubmed: 22706301
Am J Hematol. 2019 Nov;94(11):1227-1235
pubmed: 31400017
Am J Hematol. 2018 May;93(5):672-682
pubmed: 29396846
Int J Lab Hematol. 2016 Dec;38(6):629-638
pubmed: 27427187
Haematologica. 2014 Sep;99(9):e168-70
pubmed: 24895341
Blood. 2006 Mar 15;107(6):2557-61
pubmed: 16293607
Am J Hematol. 2018 Dec;93(12):1509-1517
pubmed: 30187933
Blood. 2012 Aug 30;120(9):1908-15
pubmed: 22529292
Nat Genet. 2016 Aug;48(8):895-903
pubmed: 27376235
Front Genet. 2020 Feb 19;11:76
pubmed: 32140171
Hum Mutat. 2009 Sep;30(9):1292-8
pubmed: 19621418
Haematologica. 2017 Sep;102(9):e371-e374
pubmed: 28550189
PLoS Genet. 2014 Dec 18;10(12):e1004890
pubmed: 25521328
Haematologica. 2014 Feb;99(2):252-61
pubmed: 23935018
Lancet. 2012 Jan 28;379(9813):373-83
pubmed: 21908035
Cell. 2018 May 17;173(5):1165-1178.e20
pubmed: 29706548
Br J Haematol. 2019 May;185(3):436-449
pubmed: 30836435
Eur J Haematol. 2010 Jul;85(1):20-5
pubmed: 20665989
Blood Rev. 2013 Jul;27(4):167-78
pubmed: 23664421
Am J Clin Pathol. 2017 Jul 1;148(1):6-15
pubmed: 28605432
N Engl J Med. 2019 Sep 5;381(10):933-944
pubmed: 31483964
Blood. 2015 Sep 10;126(11):1273-80
pubmed: 26148990
J Clin Invest. 2010 Dec;120(12):4453-65
pubmed: 21099109
Nucleic Acids Res. 2019 Sep 5;47(15):e90
pubmed: 31194863
Science. 2013 Oct 11;342(6155):253-7
pubmed: 24115442
Lancet. 2018 Jan 13;391(10116):155-167
pubmed: 28774421
Transfus Med Hemother. 2020 Feb;47(1):4-13
pubmed: 32110189
Clin Chem Lab Med. 2017 Mar 1;55(3):394-402
pubmed: 27559691
Cell Rep. 2016 May 31;15(9):2038-49
pubmed: 27210764
Trends Genet. 2016 Aug;32(8):485-495
pubmed: 27312344
J Clin Pathol. 2020 Aug;73(8):488-492
pubmed: 31980563
Haematologica. 2016 Nov;101(11):1284-1294
pubmed: 27756835
Blood Cells Mol Dis. 2016 Oct;61:4-9
pubmed: 27667160
Haematologica. 2018 Mar;103(3):e94-e97
pubmed: 29191841
NPJ Genom Med. 2016 Jan 13;1:
pubmed: 28567303
Eur J Hum Genet. 2017 Feb;25(2):176-182
pubmed: 27848944
Nat Genet. 2009 Aug;41(8):936-40
pubmed: 19561605
Haematologica. 2019 Aug;104(8):1554-1564
pubmed: 30655378
Hematol Oncol Clin North Am. 2016 Apr;30(2):373-93
pubmed: 27040960
Cell. 2015 May 21;161(5):1012-1025
pubmed: 25959774
Br J Haematol. 1996 May;93(2):303-10
pubmed: 8639421
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7748-E7757
pubmed: 30065114
Int J Hematol. 2018 Sep;108(3):306-311
pubmed: 29936674
Hum Genet. 2008 Nov;124(4):357-68
pubmed: 18784943
Blood. 2012 Oct 25;120(17):3586-93
pubmed: 22968456
J Mol Biol. 2020 Feb 7;432(3):653-664
pubmed: 31863747
Blood. 2013 May 9;121(19):3925-35, S1-12
pubmed: 23479567
Blood Cells Mol Dis. 2013 Jun;51(1):17-21
pubmed: 23453696
Blood. 2018 May 17;131(20):2183-2192
pubmed: 29549173
Br J Haematol. 2020 Mar;188(5):784-795
pubmed: 31602632
Ann Biol Clin (Paris). 2014 Nov-Dec;72(6):639-68
pubmed: 25486662
Am J Hematol. 2013 Jan;88(1):66-72
pubmed: 23180570
F1000Res. 2018 Aug 29;7:
pubmed: 30228860
Comput Struct Biotechnol J. 2018 Feb 15;16:43-53
pubmed: 29686798
Eur J Haematol. 2018 Sep;101(3):297-304
pubmed: 29786897
Blood. 2005 Jan 15;105(2):838-46
pubmed: 15238419
Genet Med. 2013 Sep;15(9):733-47
pubmed: 23887774
Br J Haematol. 2000 Sep;110(4):993-7
pubmed: 11054094
Ann Hematol. 2020 May;99(5):955-962
pubmed: 32266426
Expert Rev Hematol. 2016 Mar;9(3):283-96
pubmed: 26653117
Haematologica. 2017 Aug;102(8):1304-1313
pubmed: 28550188
Br J Haematol. 2016 Sep;174(5):806-14
pubmed: 27292444
Am J Hematol. 2020 May;95(5):472-482
pubmed: 32043619
Front Physiol. 2018 Apr 27;9:451
pubmed: 29755372
Br J Haematol. 2016 Oct;175(2):318-330
pubmed: 27432187
Cell. 2020 Oct 1;183(1):28-45
pubmed: 32976797
Am J Hematol. 2019 Jan;94(1):149-161
pubmed: 30358897
Nat Methods. 2011 Jan;8(1):61-5
pubmed: 21102452
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4103-8
pubmed: 24591581
Blood. 2017 Sep 14;130(11):1347-1356
pubmed: 28760888
Int J Hematol. 2019 Nov;110(5):618-626
pubmed: 31401766
Front Physiol. 2019 Sep 13;10:1063
pubmed: 31572203
Blood. 2005 Dec 15;106(13):4034-42
pubmed: 16051738
Br J Haematol. 2019 Oct;187(1):13-24
pubmed: 31364155
Mol Cell Biol. 2014 Oct 1;34(19):3721-34
pubmed: 25071156
Br J Haematol. 2019 Mar;184(5):721-734
pubmed: 30681718
Nature. 2012 Apr 11;485(7398):376-80
pubmed: 22495300
Am J Hematol. 2018 Jan;93(1):107-121
pubmed: 28971506
Blood. 1999 Nov 1;94(9):3199-204
pubmed: 10556208
Nat Med. 2019 May;25(5):776-783
pubmed: 30911135
Blood. 2020 Sep 10;136(11):1274-1283
pubmed: 32702750
Am J Hum Genet. 2002 Dec;71(6):1467-74
pubmed: 12434312
Haematologica. 2020 Jul 23;105(12):2883-2886
pubmed: 33256393
Int J Lab Hematol. 2014 Jun;36(3):388-97
pubmed: 24750686
Haematologica. 2013 Sep;98(9):1383-7
pubmed: 23716552
Int J Lab Hematol. 2019 May;41 Suppl 1:95-101
pubmed: 31069991

Auteurs

Roberta Russo (R)

Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.

Roberta Marra (R)

Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.

Barbara Eleni Rosato (BE)

Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.

Achille Iolascon (A)

Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.

Immacolata Andolfo (I)

Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.
CEINGE Biotecnologie Avanzate, Naples, Italy.

Classifications MeSH